Zobrazeno 1 - 10 of 146 pro vyhledávání: '"Christine A. Garcia"'
1
Akademický článek
Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment
Autor: James B. Bussel, Christine A. Garcia
Publikováno v: Haematologica, Vol 107, Iss 9 (2022)
This article summarizes our approach to the diagnosis of immune thrombocytopenia (ITP), its secondary forms, and choice of second-line treatment options. We very briefly summarize first-line treatment and then utilize a case-based approach. We first
Externí odkaz: https://doaj.org/article/0510b41ea5f746bd9685334ec09ca39a
Zobrazit plný text záznamu
2
Akademický článek
Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases
Autor: Christine A. Garcia, Alex El-Ali, Tanya J. Rath, Lydia C. Contis, Vikram Gorantla, Jan Drappatz, Diwakar Davar
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-6 (2018)
Abstract Background PD-1 and CTLA-4 inhibitors are associated with several adverse events including a spectrum of immune-related adverse effects (irAEs). Neurologic irAEs are uncommon occurrences with varied presentations. We describe two separate ca
Externí odkaz: https://doaj.org/article/c207564dc39b4723bfaa39525cc241e1
Zobrazit plný text záznamu
4
Akademický článek
Prevalence of pectus excavatum in an adult population-based cohort estimated from radiographic indices of chest wall shape.
Autor: Mikaela Biavati, Julia Kozlitina, Adam C Alder, Robert Foglia, Roderick W McColl, Ronald M Peshock, Robert E Kelly, Christine Kim Garcia
Publikováno v: PLoS ONE, Vol 15, Iss 5, p e0232575 (2020)
BACKGROUND:Pectus excavatum is the most common chest wall skeletal deformity. Although commonly evaluated in adolescence, its prevalence in adults is unknown. METHODS AND FINDINGS:Radiographic indices of chest wall shape were analyzed for participant
Externí odkaz: https://doaj.org/article/04bb344828ca440a970fd3298da3b207
Zobrazit plný text záznamu
7
Rare and Common Variants in KIF15 Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis
Autor: David Zhang, Gundula Povysil, Philippe H. Kobeissy, Qi Li, Binhan Wang, Mason Amelotte, Hager Jaouadi, Chad A. Newton, Toby M. Maher, Philip L. Molyneaux, Imre Noth, Fernando J. Martinez, Ganesh Raghu, Jamie L. Todd, Scott M. Palmer, Carolina Haefliger, Adam Platt, Slavé Petrovski, Joseph A. Garcia, David B. Goldstein, Christine Kim Garcia
Publikováno v: American Journal of Respiratory and Critical Care Medicine. 206:56-69
RATIONALE: Genetic studies of Idiopathic Pulmonary Fibrosis (IPF) have improved our understanding of this disease, but not all causal loci have been identified. OBJECTIVE: To identify genes enriched with rare deleterious variants in IPF and familial
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69693b5a466d227ed80c4c194dba1f88
https://doi.org/10.1164/rccm.202110-2439oc
Zobrazit plný text záznamu
9
Data from Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy
Autor: Toby A. Eyre, John N. Allan, Bruce D. Cheson, Kayla Bigelow, Colleen Dorsey, Andrew D. Zelenetz, Amber C. King, Julie M. Goodfriend, Chadi Nabhan, Hanna B. Weissbrot, Jason C. Lee, Neil Bailey, Erica B. Bhavsar, Talha Munir, Nicolas Martinez-Calle, Christopher P. Fox, Thomas D. Rodgers, Stephen J. Schuster, Timothy J. Voorhees, Kentson Lam, Rachael Pocock, Othman S. Akhtar, Pratik Shah, Krista M. Isaac, Ariel F. Grajales-Cruz, Sirin Khajavian, Andrea Sitlinger, Allison M. Winter, Kate J. Whitaker, Christine A. Garcia, Helen Parry, Craig A. Portell, Paul M. Barr, Joanna Rhodes, Catherine C. Coombs, Michael Choi, Bita Fakhri, Satyen Gohil, John M. Pagel, Jeffrey J. Pu, Pallawi Torka, Alan P. Skarbnik, Jacqueline Barrientos, Javier A. Pinilla-Ibarz, Guilherme Fleury Perini, Maryam Sarraf Yazdy, Chaitra S. Ujjani, Mazyar Shadman, Danielle Brander, Nicole Lamanna, Brian T. Hill, Ryan Jacobs, Lindsey E. Roeker, Anthony R. Mato
Purpose:Venetoclax-based therapy is a standard-of-care option in first-line and relapsed/refractory chronic lymphocytic leukemia (CLL). Patient management following venetoclax discontinuation remains nonstandard and poorly understood.Experimental Des
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e72e05cfed97bbc9e2e47db93b397aae
https://doi.org/10.1158/1078-0432.c.6528851
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje